Professor Andrew Lotery is Professor of Ophthalmology within Medicine at the University of Southampton. As a clinician scientist his research is driven by interactions with patients. He works from bench to bedside using laboratory techniques such as molecular genetics and cell biology to study common causes of blindness such as age related macular degeneration (AMD) and glaucoma. His laboratory work is complemented with clinical trials undertaken in Southampton Eye Unit. He is best known for his genetics research in retinal diseases. He has identified the genetic determinants of retinal diseases and helped to translate these into new therapies such as complement inhibitors for the commonest cause of blindness, age related macular degeneration (AMD). His innovative research in macular disease was recognised internationally by his 2004 election to the United States Macula Society. He is one of the top UK clinician scientists in eye disease as demonstrated by his election as an NIHR senior investigator in 2008 and The Times listing him in their 2010 Top 100 Doctors list. His influential research was recognised by the Royal College of Ophthalmology (RCOphth) who awarded him the Nettleship medal in 2009 for his Lancet paper on AMD genetics. He received the 2012 special award for excellence from the Macular Disease Society and the 2014 University Hospital Southampton Innovation Award. He is editor-in-chief of the Nature publication: Eye since 2008 and former President of the Southern Ophthalmological Society. In influencing policy to improve health and wealth, Andrew has beena member of the Department of Transport’s honorary medical advisory panel on driving and visual disorders since 2013. He has acted as a nominated clinical expert to The National Institute for Heath and Care Excellence (NICE) technology appraisal panels that have resulted in major changes in management of AMD and vitreo-macular traction. As co-chair of the RCOphth academic committee, he initiated co-funded clinical training fellowships with the MRC. Andrew is specialty lead for the Wessex Clinical Research Network spearheading a major increase in clinical trials in Wessex over the last 5 years. He has contributed significant AMD samples to an international effort to find novel genetic determinants for AMD. This has resulted in over 20 novel genes been identified.

Professor Saadettin Sel is an ophthalmic surgeon (anterior and posterior eye segment). Corneal and vitreoretinal specialist. Has an extensive experience in a wide variety of other eye conditions, including cataracts, uveitis, glaucoma and trauma. Obtained research funding through peer review process from German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, http://gepris.dfg.de/gepris/person/166741536), Federal Ministry for Economics Affairs and Energy (Bundesministerium für Wirtschaft und Energie, BMWi) and European Union (Framework Programmes for Research and Technological Development). Published more than 100 scientific articles in peer-reviewed journals and book chapters

Martin Dirisamer is cornea consultant in the Department of Ophthamology at the University of Munich. Martin Dirisamr completed his PhD at Vienna University. Martin Dirisamer is a co-founder and Co-owner of ‘SMILE EYES Linz’ (Eye Laser Center).He received more than 10 awards for his work in the department of Ophthamology. Martin Dirisamer is a reviewer for more than 9 Journals.

Guber Ivo is a Consultant ophthalmic surgeon, Cornea and refractive surgery unit in the Department of Ophthalmology, University of Geneva, Switzerland. He worked as an Associate professor in the University of Zurich.Ivo Guber is awarded the Federo post graduatee training title of specialist in ophthalmology

Rory McCrimmon trained at the University of Edinburgh and completed his clinical and speciality training in the South-East of Scotland before becoming an NHS Consultant Physician in Diabetes and Endocrinology at University Hospital Aintree, Liverpool, in 2000. In 2002, he joined the faculty at Yale University, Connecticut, to investigate why people with type 1 and 2 diabetes are very prone to developing low glucose (Hypoglycaemia). He returned to Scotland in 2009 to establish his laboratory at the University of Dundee, where he is currently Professor of Experimental Diabetes and Metabolism and Honorary Consultant, and to develop his clinical interests in Hypoglycaemia Unawareness and Exercise in Type 1 diabetes. He was recently awarded the 2015 RD Lawrence Lecture by Diabetes UK for his research in Hypoglycaemia. Prof McCrimmon is currently also Lead Clinician for the Scottish Diabetes Research Network (SDRN), which provides the necessary infrastructure to co-ordinate and enable academic and commercial research throughout Scotland. The SDRN hosts a National Research Register of over 11,000 subjects with diabetes pre-consented to be contacted about clinical trials. The register is directly linked to SCI-diabetes, which contains secure clinical and biochemical data on over 350,000 people with diabetes in Scotland. Prof McCrimmon is currently research lead for the Academic Health Sciences Partnership in Tayside. Serves on Editorial Boards of Diabetologia, Diabetes Care and the Journal of Endocrinology and Metabolism. He is a panel member for: Diabetes UK, Clinical Studies Group Management Committee; Diabetes UK, Intermediate Clinical Fellowships Panel; Juvenile Diabetes Research Foundation PEAK Programme; Panel member, International Hypoglycaemia Study Group; Panel Member Medical Research Council Clinical Fellowship Training and Career Development Awards panel; Panel Member, Research Advisory Board, Diabetes Research & Wellness Foundation.

Prof. of Ophthalmology, Tanta University, Tanta, Egypt. Fellow, University of Tennessee, Center for Health Sciences, Memphis, TN, USA. President of Egyptian Refractive Club (ERC). Chairman of Horus Vision Correction Center, Alexandria, Egypt. Reviewer of Journal Cataract Refractive Surgery (JCRS). Reviewer of Journal of Refractive Surgery (JRS). Reviewer of International Journal of Ophthalmology (IJO). Member of AAO since 1985. Member of ASCRS since 1991. Member of ESCRS since 1995. Ultraspeciality: Cornea, Cataract IOL, Refractive Surgery, Surgical Management of Presbyopia.

Dr. Elias L. Warrak is a professor in the Departments of Ophthalmology, at St. George University Medical center, Balamad University. Dr. Elias L. Warrak research focuses on Corneal tissue replacement for intracorneal ring extrusion, Intracorneal rings in Keratoconus, Anterior capsulorrhexis tissue implantation in Pterygium surgery and Genetic mapping in families with Keratoconus.